News
Climate change and air pollution are growing threats to public health, and new research suggests they may also worsen atopic ...
A new study found that patients with hemophilia A could safely switch directly from emicizumab to Mim8 without a washout period, meaning they did not need to stop treatment before starting the new ...
Sonali Kulkarni, M.D., M.P.H., Medical Director in the Division of HIV and STD Programs at the Los Angeles County Department ...
Health insurers and others decry the steep cuts in Medicaid spending that are projected to total approximately $1 trillion over the next 10 years.
Care gaps in women’s health are closing, thanks to increased cultural awareness of gendered healthcare disparities, according ...
Absent a federal committee’s recommendation, Duchenne muscular dystrophy advocates are trying to get states to adopt ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...
Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...
Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.
For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results